Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort

Keyphrases

• 28-day Mortality 25%
• 3-group 8%
• Ancillary 100%
• Cause-specific Hazard 8%
• Clinical Trial Registry 8%
• Competing Events 8%
• COVID-19 16%
• COVID-19 Patients 100%
• Cox Regression Model 8%
• European Cohort 8%
• Events of Interest 8%
• Extubation 8%
• High Risk 16%
• ICU Admission 8%
• ICU Discharge 8%
• ICU Stay 16%
• Influenza 16%
• Influenza Pneumonia 16%
• Microbiological Criteria 8%
• Multivariable 8%
• No Significant Difference 8%
• SARS-CoV-2 Infection 8%
• SARS-CoV-2 Patients 25%
• SARS-CoV-2 Pneumonia 16%
• Ventilation Rate 16%
• Ventilator-associated Pneumonia 100%
• Viral Infection 33%

Medicine and Dentistry

• Artificial Respiration 16%
• Clinical Trial 8%
• COVID-19 100%
• Extubation 8%
• Infection 8%
• Mortality Rate 8%
• Proportional Hazards Model 8%
• Severe Acute Respiratory Syndrome Coronavirus 2 66%
• Ventilator-Associated Pneumonia 100%
• Virus Infection 33%

Nursing and Health Professions

• Artificial Respiration 16%
• Extubation 8%
• Infection 8%
• Mortality Rate 8%
• Proportional Hazards Model 8%
• Severe Acute Respiratory Syndrome 66%
• Ventilator-Associated Pneumonia 100%
• Virus Infection 33%